Company intelligence / Profile preview

Sailormen

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~125
Development stage: Other

Overview

Sail Biomedicines is a Flagship Pioneering company focused on the development of fully programmable RNA medicines. Formed in 2023 through the merger of Laronde and Senda Biosciences, the company integrates circular RNA technology, known as Endless RNA (eRNA), with a proprietary targeted nanoparticle (TNP) delivery system. Sail's platform utilizes generative AI to design medicines that offer prolonged protein expression and precise, extra-hepatic delivery. The company's lead development candidate, SAIL-0804, is an in vivo CAR-T therapy designed to treat autoimmune diseases by depleting disease-causing B cells. Sail aims to transform patient care across immunology, infectious diseases, and metabolic disorders through its modular and repeatable programmable medicine toolkit.

Therapeutic areas: ImmunologyInfectious DiseasesRare DiseasesMetabolic DisordersOncology
Modalities: mRNA-based drugsCircular RNAEndless RNALipid nanoparticle delivery therapyTargeted nanoparticlesCAR-T cell therapy
Industry: Biotech

Partnerships

Flagship Pioneering

Beyond the preview

Go deeper on Sailormen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sailormen.

Explore the full profile